Introduction

The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had an unprecedented socioeconomic and public health impact worldwide. The availability of accurate COVID-19 diagnostic tests is one of the cornerstones of tackling the pandemic [1,2,3,4,5].

Today, real-time reverse transcription quantitative polymerase chain reaction (RT-qPCR) is considered the “gold standard” assay for the diagnosis of both symptomatic and asymptomatic cases [6] and is included in the protocols issued by several international institutional bodies [7, 8]. These commonly used protocols involve a ribonucleic acid (RNA) extraction step, which may be seen as a major bottleneck in the routine laboratory testing process [9].

Since March 2020, some manufacturers have reported supply shortages of RNA extraction kits, owing to the sudden increase in their global demand. This situation has called for alternative protocols with similarly high diagnostic accuracy, in order to ensure the continuity of testing [10,11,12,13]. Consequently, various direct approaches that avoid RNA extraction have been suggested, including heat-processed methods [9, 14].

The objective of this study was to evaluate the diagnostic performance of two different extraction-free RT-qPCR techniques and to compare their performance with that of the traditional extraction-based method in a real-world setting.

Materials and methods

In this study, a total of 98 fresh nasopharyngeal swabs routinely and prospectively collected in October 2020 from COVID-19 symptomatic individuals were analyzed. All these samples were deemed positive according to the traditional extraction-based (EB) RT-qPCR technique. During an internal discussion, it was decided that a sample size of 100 positive samples would be sufficiently powered to determine a sensitivity of 90% [15, 16] provided by the RNA extraction-free (EF) methods. It was assumed that the specificity of the EF method was 100%. During execution of the study, two samples from previously known positive subjects yielded invalid results (i.e., the internal control was not amplified) in the EB RT-qPCR and were therefore excluded from the analysis.

Each sample analyzed was eluted in universal transport medium (UTM™, Copan Diagnostics Inc., USA) and processed at the regional reference laboratory for COVID-19 diagnosis of the San Martino Policlinico Hospital (Genoa, Liguria, Northwest Italy).

All samples were processed on the same day using three methods: (i) a standard EB method performed with STARMag 96x4 Viral DNA/RNA 200C Kit (Seegene Inc., South Korea), (ii) an RNA extraction-free (EF) method with a heating step (EFh+), and (iii) an unheated EF technique (EFh–).

For the EB method, total RNA was extracted using a STARMag Universal Cartridge Kit (Seegene Inc., South Korea) on an automated Nimbus IVD (Seegene Inc., South Korea) platform. As recommended by the manufacturer, a total of 200 µl of each sample was extracted and eluted with 100 µl of elution buffer and set up for RT-qPCR [17].

For the EFh– technique, an input volume of 5 µl of each sample diluted 1:3 with molecular-grade water was used directly for RT-qPCR. By contrast, for the EFh+ method, thermolysis was first performed at 95°C for 3 min and at 4°C for 5 min on a Bio-Rad CFX96™ thermal cycler (Bio-Rad Laboratories, USA).

RT-qPCR was performed on a CFX96™ instrument (Bio-Rad Laboratories, USA) using an Allplex™ 2019-nCoV assay (Seegene Inc., South Korea). This is a multiplex RT-qPCR assay that is able to simultaneously detect three different genes, targeting the nucleoprotein region (N), the RNA-dependent RNA-polymerase (RdRp)/spike (S) region, and the envelope (E) region. Amplification was performed at 50°C for 20 min, followed by 95°C for 15 min and 45 cycles at 95°C for 10 s, 60°C for 15 s with first acquisition, and 72°C for 10 s with second acquisition on a CFX96™ thermal cycler. For each reaction, 5 µl of the extracted RNA in a final volume of 20 µl was used. According to the manufacturer, the analytical specificity of this method is 100% [17].

In the analysis, samples yielding a cycle threshold (Ct) value <40 for at least two genes were considered positive.

The standard EB technique was considered a reference method against both EFh+ and EFh–. A sensitivity value with 95% confidence intervals (CIs) was calculated. As the observed Ct values were approximately normally distributed, the average target-specific differences in Ct values among the three techniques were computed and compared by applying repeated-measures analysis of variance (ANOVA) and the follow-up Tukey honestly significant difference post-hoc test. Data were analyzed in R stats packages, v. 4.0.3 [18].

Results

When using the traditional EB technique as the “gold standard”, the EFh– method displayed perfect accordance, with no false negative results (sensitivity of 100% [95% CI: 95.3–100%]). By contrast, a total of eight (8.2%) swabs treated as per the EFh+ methodology were deemed false negative, giving a sensitivity of 91.8% (95% CI: 84.1–96.2%). As per the EB method, all of these specimens had Ct values >30. These discordant samples were retested, and the initial result was confirmed.

Figure 1 and Table 1 report the summary distributions and mean differences of Ct values according to the technique used and gene target. The omnibus ANOVA test rejected (P < 0.001) the null hypothesis that Ct values yielded by the three methods had identical means; moreover, all of the pairwise post-hoc comparisons were also statistically significant (P < 0.01). Indeed, the average Ct value for any gene was lowest in the EB group and highest in the EFh+ group. Moreover, the highest between-method difference concerned the RdRp/S gene, and the lowest, the N gene (Table 1). Of note, all eight false negatives determined by the EFh+ method had a Ct value >30, regardless of the gene target (average of 34.1, 34.5, and 32.9 for the E, RdRp/S, and N gene, respectively).

Fig. 1
figure 1

Distribution of the cycle threshold values by method used and gene target

Table 1 Mean absolute difference in cycle threshold values by method used and gene target*

Discussion

In the context of the COVID-19 pandemic, it is crucial to obtain rapid and reliable results in order to diagnose patients and take timely public health decisions. Here, we demonstrated that EF methods may be valuable alternatives to traditional EB techniques. This study adds to the growing body of evidence of the utility of extraction-free methods of detecting SARS-CoV-2.

Several EF protocols have recently been described and validated [9, 15, 19,20,21,22,23,24]. Across these studies, the relative sensitivity of EF techniques has been seen to vary from 55% to >95%. In our study, the RT-qPCR readout yielded by the direct EFh– method was in complete agreement with the traditional EB technique. Although there were significant differences between the Ct values obtained by these two methods, no disagreement in the interpretation of the overall output was found. On the other hand, we found some negative effect of heat inactivation on virus detection. This, however, affected only samples with low viral loads (Ct >30). Cameron et al. [19] observed a relative sensitivity of EFh+ (heat treatment at 95°C for 10 min) vs. EB of 100% for specimens with Ct values ≤ 25. This value, however, dropped to 22–33% for specimens with Ct values >35 [19]. Similarly, Zou et al. [20] reported that, following heat treatment, about 13.0% of positive swabs became negative; all of these false negatives had a Ct value ≥37. Grant et al. [21] also observed lower Ct values in unheated samples. Our results are also consistent with those of a recent study by Burton et al. [22]. Indeed, these authors observed that, in comparison with unheated samples, heat treatment at 95°C for 5 min increased the average Ct by 4.5–6 cycles. The application of lower heating regimens may therefore be useful in order to increase the sensitivity of the EFh+ method and should be investigated further. For instance, Burton et al. [22] did not register any significant differences on implementing heating regimens of 56/60°C. In sum, in line with the available evidence [9, 15, 19,20,21,22,23,24], our results support the use of EF techniques in routine practice. The heat treatment procedure introduced in order to lyse epithelial cells may, however, reduce sensitivity. The differences in the sensitivity values reported are most probably attributable to different EF protocols adopted in single studies, including, for example, the relative distribution of specimens with different Ct values, sample storage, heat inactivation regimen, etc. Therefore, a well-established and recognized EF protocol is warranted.

At least two study limitations may affect the overall interpretation of our findings. First, we assumed that the specificity of EB RT-qPCR was 100%; therefore, no EB-based negative samples were analyzed in the present study. Second, for the fully concordant samples (91.8%, 90/98), only one replicate for each RT-qPCR technique was used.

In conclusion, our data suggest that EF methods (especially unheated) are a useful tool in providing RT-qPCR results in a shorter time, thereby speeding up clinical diagnostics and the subsequent burden on molecular labs and hospitals. Indeed, the average processing times in our study were 270, 163, and 156 min for the standard EB, EFh+, and EFh–, respectively. These EF methods therefore urgently require an internationally recognized protocol.